Speaker illustration

Professor Christopher B Granger

Duke University Medical Center, Durham (United States of America)

Member of:

European Society of Cardiology

Dr. Granger is Professor of Medicine and Nursing at Duke University and at the Duke Clinical Research Institute. His primary research interests are in conduct and methodology of randomized clinical trials in heart disease and implementation research to more effectively apply proven therapies. He has co-authored over 900 peer-reviewed manuscripts and is in the top 1% of researchers by Clarivate Analytics. He has chaired steering committees on many multicenter randomized clinical trials in acute cardiovascular care, heart failure, and atrial fibrillation. He is past Chairman of the American Heart Association Mission: Lifeline program. He is a member of ACC/AHA guideline committees for ST-Segment Elevation Myocardial Infarction, for the Focused Update on Duration of Dual Antiplatelet Therapy in Patients with Coronary Artery Disease, and for Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. He leads the RACE-CARS cluster randomized trial funded by the NHLBI.

Out-of-hospital cardiac arrest: how to move the needle in outcome

Event: ESC Acute CardioVascular Care 2022

Topic: Management of Out-of-Hospital Cardiac Arrest

Session type: How To ...

Thumbnail

All about cardiac arrest

Event: ESC Acute CardioVascular Care 2022

Topic: Acute Cardiac Care

Session type: Abstract Sessions

Thumbnail

Atrial fibrillation in the context of acute coronary syndromes and coronary intervention: what should we do?

Event: ESC Congress 2018

Topic: Arrhythmias, General

Session type: Symposium

Thumbnail

Biomarker-based approaches for improved atrial fibrillation management

Event: ESC Congress 2018

Topic: Atrial Fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

The unavoidable impact of big data in acute cardiovascular care

Event: Acute Cardiovascular Care 2018

Topic: Miscellaneous

Session type: Symposium

Thumbnail

Controversies in patients with NSTEMI

Event: Acute Cardiovascular Care 2018

Topic: Acute Coronary Syndromes

Session type: Debate Session

Thumbnail

Tailoring oral anticoagulation strategies in atrial fibrillation: spotlight on renally impaired and elderly patients

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

Changing the face of anticoagulation: 5 years since RE-LY®

Event: ESC CONGRESS 2014

Topic: Thrombosis and coagulation

Session type: Satellite Symposium

Thumbnail

Stroke prevention in non-valvular atrial fibrillation - Improving patient outcomes

Event: ESC Congress 2013

Topic: Primary cardiovascular prevention: interventions and outcomes

Session type: Satellite Symposium

Thumbnail

Antiplatelet therapy in acute coronary syndromes: translating evidence into clinical practice to improve outcomes

Event: ESC Congress 2013

Topic: Antithrombotic agents

Session type: EBAC Accredited Educational Programme

Thumbnail

ESC 365 is supported by

logo Novo Nordisk